Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Xanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic Mice
Yu Mizuno, Takeshi Yamamotoya, Yusuke Nakatsu, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 19, pp. 4680-4680
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors
Ning Liu, Hu Xu, Qianqian Sun, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 163
Inhibition of Xanthine Oxidase Protects against Diabetic Kidney Disease through the Amelioration of Oxidative Stress via VEGF/VEGFR Axis and NOX-FoxO3a-eNOS Signaling Pathway
Keum‐Jin Yang, Won Jung Choi, Yoon-Kyung Chang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3807-3807
Open Access | Times Cited: 20
Emerging Roles of Xanthine Oxidoreductase in Chronic Kidney Disease
Hunter Korsmo, Ubong S. Ekperikpe, Ilse S. Daehn
Antioxidants (2024) Vol. 13, Iss. 6, pp. 712-712
Open Access | Times Cited: 7
Regulation of Vascular Function and Inflammation via Cross Talk of Reactive Oxygen and Nitrogen Species from Mitochondria or NADPH Oxidase—Implications for Diabetes Progression
Andreas Daiber, Sebastian Steven, Ksenija Vujačić-Mirski, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3405-3405
Open Access | Times Cited: 41
Mechanistic insights into hyperuricemia-associated renal abnormalities with special emphasis on epithelial-to-mesenchymal transition: Pathologic implications and putative pharmacologic targets
Pitchai Balakumar, Ali Alqahtani, Noohu Abdulla Khan, et al.
Pharmacological Research (2020) Vol. 161, pp. 105209-105209
Closed Access | Times Cited: 40
Febuxostat provides renoprotection in patients with hyperuricemia or gout: a systematic review and meta-analysis of randomized controlled trials
Xiu Hong Yang, Bao Long Zhang, Yun Cheng, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 6
Oral Administration of Lipopolysaccharide Enhances Insulin Signaling-Related Factors in the KK/Ay Mouse Model of Type 2 Diabetes Mellitus
Kazushi Yamamoto, Masashi Yamashita, Masataka Oda, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4619-4619
Open Access | Times Cited: 10
Synthesis and spectral characterization of 4-methylthiazole derivatives: DFT approach and biological activities
Pakkirisamy Sivakumar, S. Bharanidharan, Rajaram Rajamohan, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 34, pp. 16216-16227
Closed Access | Times Cited: 10
Hyperuricemia-induced complications: dysfunctional macrophages serve as a potential bridge
Wenyi Gu, Jiajing Zhao, Yu Xu
Frontiers in Immunology (2025) Vol. 16
Open Access
Serum Uric Acid Is Associated with Insulin Resistance in Non-Diabetic Subjects
Janis Timsans, Jenni Kauppi, Vappu Rantalaiho, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2621-2621
Open Access
Metabolic crosstalk and therapeutic interplay between diabetes and hyperuricemia
Tianshu Yang, Lingyun Luo, Xuelian Luo, et al.
Diabetes Research and Clinical Practice (2025) Vol. 224, pp. 112204-112204
Open Access
Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2
Asmaa Mohamed Abdel‐Aziz, Nashwa Fathy Gamal El‐Tahawy, Medhat Atta Salah Abdel haleem, et al.
European Journal of Pharmacology (2020) Vol. 889, pp. 173631-173631
Closed Access | Times Cited: 27
Febuxostat attenuates secondary brain injury caused by cerebral hemorrhage through inhibiting inflammatory pathways.
Yang Bai, Hongxia Shi, Ying Zhang, et al.
PubMed (2024) Vol. 27, Iss. 6, pp. 740-746
Closed Access | Times Cited: 3
The Crucial Role of Xanthine Oxidase in CKD Progression Associated with Hypercholesterolemia
Jongbin Kim, Sehyun Oh, Ji‐Sun Ahn, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7444-7444
Open Access | Times Cited: 21
Hyperuricemia Predicts the Progression of Type 2 Diabetic Kidney Disease in Chinese Patients
Lin Zhu, Xuening Wang, Jiaxing Sun, et al.
Diabetes Therapy (2023)
Open Access | Times Cited: 8
Cardio-renal protective effect of the xanthine oxidase inhibitor febuxostat in the 5/6 nephrectomy model with hyperuricemia
Hiroki Omizo, Yoshifuru Tamura, Chikayuki Morimoto, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Effect of the Xanthine Oxidase Inhibitor, Febuxostat, on WBC Count in Asymptomatic Hyperuricemia: Subanalysis of the Randomized PRIZE Study
Mitsuhide Takeshita, Atsushi Tanaka, Hisako Yoshida, et al.
Journal of Atherosclerosis and Thrombosis (2024) Vol. 31, Iss. 6, pp. 864-875
Open Access | Times Cited: 2
Kidney Inflammation, Injury and Regeneration
Patrick C. Baer, Benjamin Koch, Helmut Geiger
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1164-1164
Open Access | Times Cited: 17
Febuxostat Attenuates the Progression of Periodontitis in Rats
Naseratun Nessa, Miyuki Kobara, Hiroe Toba, et al.
Pharmacology (2021) Vol. 106, Iss. 5-6, pp. 294-304
Closed Access | Times Cited: 15
Comparing the Effects of Febuxostat and Allopurinol in an Animal Model of Metabolic Syndrome
Eman Hassan Nadwa, George N.B. Morcos, Nagwan M. Salama, et al.
Pharmacology (2021) Vol. 106, Iss. 9-10, pp. 564-572
Closed Access | Times Cited: 13
Effect of febuxostat on the level of malondialdehyde‐modified low‐density lipoprotein, an oxidative stress marker: A subanalysis of the PRIZE study
Hiroki Teragawa, Atsushi Tanaka, Yuichi Fujii, et al.
Clinical Cardiology (2023) Vol. 46, Iss. 6, pp. 698-706
Open Access | Times Cited: 5
Febuxostat Prevents the Cytotoxicity of Propofol in Brain Endothelial Cells
Jianli Hao, Weiqing Zhang, Rui Tong, et al.
ACS Omega (2021) Vol. 6, Iss. 8, pp. 5471-5478
Open Access | Times Cited: 11
The Management of Diabetes with Hyperuricemia: Can We Hit Two Birds with One Stone?
Yunyang Wang, Jie Lü
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 6431-6441
Open Access | Times Cited: 4
Febuxostat mitigates concanavalin A-induced acute liver injury via modulation of MCP-1, IL-1β, TNF-α, neutrophil infiltration, and apoptosis in mice
Mohammed M. Maresh, Rania R. Abdеlaziz, Tarek M. Ibrahim
Life Sciences (2020) Vol. 260, pp. 118307-118307
Closed Access | Times Cited: 11
Reno-protective effect of fenofibrate and febuxostat against vancomycin-induced acute renal injury in rats: Targeting PPARγ/NF-κB/COX-II and AMPK/Nrf2/HO-1 signaling pathways
Ehab A. M. El‐Shoura, Souty M. Z. Sharkawi, Lobna A. Abdelzaher, et al.
Immunopharmacology and Immunotoxicology (2024) Vol. 46, Iss. 4, pp. 509-520
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top